	US 12,263,252 B2
	Biotherapy for viral infections using biopolymer based micro/nanogels
Madhavan Nair, Coral Gables, FL (US); Andrea Raymond, Coconut Creek, FL (US); and Arti Vashist, Miami, FL (US)
Assigned to The Florida International University Board of Trustees, Miami, FL (US)
Filed by THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES, Miami, FL (US)
Filed on Nov. 18, 2024, as Appl. No. 18/950,649.
Application 18/950,649 is a division of application No. 17/615,940, granted, now 12,144,897, previously published as PCT/US2020/036292, filed on Jun. 5, 2020.
Application 17/615,940 is a continuation in part of application No. 16/432,320, filed on Jun. 5, 2019, abandoned.
Prior Publication US 2025/0073178 A1, Mar. 6, 2025
Int. Cl. A61K 9/51 (2006.01); A61K 9/107 (2006.01); A61K 9/20 (2006.01)

CPC A61K 9/5161 (2013.01) [A61K 9/1075 (2013.01); A61K 9/2081 (2013.01); A61K 9/5146 (2013.01)]

13 Claims

1. A method of treatment for a viral infection, comprising administering to a subject in need of such treatment biopolymer-based hydrogel nanoparticles, said biopolymer-based hydrogel nanoparticles having a core-shell structure and comprising one or more biopolymers selected from hydroxylpropylcellulose (HPC), carboxymethyl cellulose (CMC), methyl cellulose (MC), starches, pectin, chitosan, and hydroxyethyl cellulose (HEC), and linseed oil polyol.